Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Testosterone reduces key molecules needed for early pregnancy in rats.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Multimodal recruitment effectively gathered a diverse group for an online survey on ovulation and menstruation health.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Eye drops with β-blockers may cause hair loss.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

An ovarian tumor can cause high male hormones in postmenopausal women.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

A woman developed male characteristics after using unregulated hormone therapy.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Ovarian vein sampling helped diagnose rare ovarian tumors causing high testosterone, and surgery to remove the tumors lowered the testosterone levels.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.